In an Unsteady Banking Industry, First Republic’s Problems Stood Out
Posted inBanking and Financial Institutions Company Reports Credit and Debt Federal Reserve System First Republic Bank High Net Worth Individuals Interest Rates Real Estate (Commercial) Regulation and Deregulation of Industry Signature Bank Silicon Valley Bank Stocks and Bonds United States

In an Unsteady Banking Industry, First Republic’s Problems Stood Out

The bank’s rivals appear on firmer footing this time, in contrast with the widespread panic after the failures of Silicon Valley Bank and Signature Bank in March.
National Academies Members Demand Answers About Sacklers’ Donations
Posted inDrugs (Pharmaceuticals) National Academies of Sciences, Engineering and Medicine Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Philanthropy Purdue Pharma Sackler Family Science and Technology United States United States Politics and Government

National Academies Members Demand Answers About Sacklers’ Donations

The Academies accepted millions of dollars from members of the Sackler family — including some who led Purdue Pharma, makers of OxyContin — even while advising federal officials on opioid policy.
As Regulators Block Tech Deals, They Increasingly Look to the Future
Posted inAntitrust Laws and Competition Issues Competition and Markets Authority (Great Britain) Computer and Video Games Computers and the Internet Federal Trade Commission Great Britain Mergers, Acquisitions and Divestitures Microsoft Corp Regulation and Deregulation of Industry United States

As Regulators Block Tech Deals, They Increasingly Look to the Future

British regulators cited the newness of the cloud gaming field to block Microsoft’s $69 billion acquisition of Activision, a shift in antitrust strategy.